These NRCC fundraising texts are getting intense pic.twitter.com/2Smm3NXCYy
— Andrew Solender (@AndrewSolender) October 14, 2021
— OSSIMP PATROL (@OssimpPatrol) October 14, 2021
These NRCC fundraising texts are getting intense pic.twitter.com/2Smm3NXCYy
— Andrew Solender (@AndrewSolender) October 14, 2021
— OSSIMP PATROL (@OssimpPatrol) October 14, 2021
A cabinet minister in the US has been on leave for months and no one noticed https://t.co/6i7HVxIMRW
— Bruno Maçães (@MacaesBruno) October 15, 2021
Клинтон примљен у болницу pic.twitter.com/ffG4LQ4eJd
— Ујка (@IvanVrsac) October 15, 2021
A study from the National Academy of Sciences tells that story: the federal government spent $100bn to subsidize the research on every single one of the 200-plus drugs approved for sale in the United States between 2010 and 2016.
Because we the public invested early in these medicines, we reduced the R&D costs for pharmaceutical companies. Therefore, on the back end, the public should have received some sort of return in the form of affordable prices. After all, we took the initial risk, and we lowered the overhead costs that the drug companies might need to recoup through higher prices. In business terms, the public is the early venture investor in these products, and we deserve a share of the returns when the product proves valuable.
However, in the mid-1990s, that business axiom was tossed out when drug lobbyists persuaded the Clinton administration to repeal rules that allowed federal officials to require government-subsidized drugs to be offered to Americans at a “reasonable price”.
A few years later, Congress – with then-Senator Joe Biden’s help – voted down legislation to reinstate these rules, and later the Obama administration rejected House Democrats’ request that federal officials at least provide guidelines to government agencies about how they can exercise their remaining powers to combat drug price gouging.
The result: we now routinely face immoral situations like last week’s news that pharmaceutical giant Merck is planning to charge Americans $712 for a Covid drug that cost only $17.74 to produce and whose development was subsidized by the American government.
This opposition is just the latest crusade to keep the American market walled off for maximum manipulation. Laws written by drug lobbyists prohibit wholesalers from importing lower-priced medicines from other countries, give drug companies 20-year patents on government-subsidized medicine, prevent the government from requiring reasonable prices for drugs the government pays for and block Medicare from using its bulk purchasing power to negotiate lower prices.
Political identities are getting funnier pic.twitter.com/ealIuKU8FY
— Aparición (jalohuín) (@ElParece) October 19, 2021
MNE wrote:Ova? Da.